Part Details | LORAZEPAM INJECTION
6505-01-650-2678
Alternate Parts: 1389520, 6505NCM152487, NDC00641605110, NDC00641-6051-10, NDC00641604710, NDC00641-6047-10, NDC00641600210, NDC00641-6002-10, 6505-01-650-2678, 01-650-2678, 6505016502678, 016502678
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | NOV 24, 2015 | 01-650-2678 | 50832 ( LORAZEPAM INJECTION ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-650-2678
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| 1389520 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| 6505NCM152487 | 64616 | DEFENSE MEDICAL STANDARDIZATIONBOARD |
| NDC00641-6051-10 | 32655 | WEST-WARD PHARMACEUTICALS CORP. |
| NDC00641-6047-10 | 32655 | WEST-WARD PHARMACEUTICALS CORP. |
| NDC00641-6002-10 | 32655 | WEST-WARD PHARMACEUTICALS CORP. |
Technical Data | NSN 6505-01-650-2678
| Characteristic | Specifications |
|---|---|
| PRIMARY CONTAINER CONTENT QUANTITY | 10.0 MILLILITERS |
| PRIMARY CONTAINER TYPE | VIAL |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | BL40.0 MILLIGRAMS LORAZEPAM |
| PHARMACEUTICAL VEHICLE TYPE | B ANY ACCEPTABLE |
| ADMINISTRATION | INTRAVENOUS AND INTRAMUSCULAR |
| TOTAL PRIMARY CONTAINER QUANTITY | 10 |
| SPECIAL FEATURES | FOR INTRAVENOUS OR INTRAMUSCULAR ADMINISTRATION; DEA CONTROLLED SUBSTANCE CLASS IV; CONCENTRATION: 4 MG/ML; STRENGTH: 40 MG/10 ML; FILL VOLUME/UNIT SIZE: 10 ML; EACH ML CONTAINS 4 MILLIGRAMS OF LORAZEPAM; STORE IN A REFRIGERATOR 2 TO 8 C (36 TO 46 F); PROTECT FROM LIGHT |
| PROTECTIVE STORAGE FEATURE | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | ATIVAN (LORAZEPAM) 40 MG MDV 10 MLS PER VIAL, 10 VIALS PER PACKAGE |
| CONTROLLED SUBSTANCE CLASSIFICATION | SCHEDULE IV |